January 12, 2026 - Health Technology Insights

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

MindMed Rebrands as Definium for Late-Stage Psychiatry Pipeline

Topline Data from Three Phase 3 Studies Evaluating DT120 Orally Disintegrating Tablet (ODT) for GAD and MDD Expected in 2026: Voyage in 2Q, Panorama in 2H, and Emerge Mid-Year...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

Sanofi’s Teizeild Approved in the EU for Patients With stage 2 type 1 diabetes

Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D patients The European Commission has approved...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

Zymeworks Updates Leadership to Support New Corporate Strategy

Investment industry veteran Mr. Brian Cherry appointed to Board of Directors Zymeworks Inc., a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

QIAGEN Sets 2026 Priorities to Drive Profitable Growth

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined annual pillar sales in...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

Diorasis Therapeutics Appoints Richard A. Kresch, to Board of Directors

Seasoned healthcare entrepreneur with multiple exits strengthens governance as the company advances durable glaucoma gene therapy toward clinical development Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

Stoke Therapeutics Updates EMPEROR Study Timelines

Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA submission planned to initiate in first half...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

Alnylam Launches “Alnylam 2030” Growth and Impact Strategy

Full Year 2025 Preliminary* Net Product Revenues of $2,987 Million (81% Growth vs. 2024), Driven Primarily by Preliminary* Total TTR Revenues of $2,487 Million (103% Growth vs. 2024) Alnylam...

January 12, 2026
HealthTech Media Room
HealthTech News, news, News

Oxford Nanopore Wins UK, Europe Approval for First Diagnostic Device

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic (“IVD”) device in the UK and Europe: the GridION™ Dx. Oxford Nanopore...

January 12, 2026
HealthTech Media Room
HealthTech News, News, news

HealthcareAI.com Emerges as Key Asset in Medical AI Sector

As the convergence of medicine and artificial intelligence accelerates globally, LaserAI.com, a leading digital asset investment firm led by Aaron Whitfield, highlighted the strategic significance of its premium holding, HealthcareAI.com. Health Technology...

January 12, 2026
HealthTech Staff Writer
HealthTech News, News, news

Prescryptive and Ilant Health Expand Employer GLP-1 Access

Prescryptive and Ilant Health have announced a partnership aimed at giving employers direct access to GLP-1 therapies with transparent pricing and expert clinical care. This collaboration leverages Prescryptive’s direct-to-market...

January 12, 2026
HealthTech Staff Writer
HealthTech News, News, news

Mary Free Bed at Home Named Among Best Home Health Agencies 2026

Mary Free Bed at Home has been recognized by Newsweek and Statista as one of America’s Best Home Health Agencies for 2026. The agency ranked fifth in Michigan and...

January 12, 2026
HealthTech Staff Writer
HealthTech News, News, news

Lucent Health Appoints Aadam Hussain as CEO After Rodewald Retires

Lucent Health, one of the largest independent third-party administrators in the United States, has announced the appointment of Aadam Hussain as Chief Executive Officer, effective January 5, 2026. This...